Effect of tobramycin on fractional sodium excretion in neonates

dc.contributor.authorRothberg, A. D.en
dc.contributor.authorAndronikou, S.en
dc.date.accessioned2015-11-24T19:22:16Z
dc.date.available2015-11-24T19:22:16Z
dc.identifier.issn0270-322X-
dc.identifier.urihttps://olympias.lib.uoi.gr/jspui/handle/123456789/22154
dc.rightsDefault Licence-
dc.subjectAminoglycosides/therapeutic useen
dc.subjectCreatinine/blooden
dc.subjectHumansen
dc.subjectInfant, Newbornen
dc.subjectRespiratory Distress Syndrome, Newborn/drug therapy/*urineen
dc.subjectSodium/*urineen
dc.subjectTobramycin/*therapeutic useen
dc.subjectUrea/blooden
dc.titleEffect of tobramycin on fractional sodium excretion in neonatesen
heal.abstractFractional sodium excretion (FENa) was measured in 25 neonates during and after treatment with tobramycin. Mean birthweight of infants was 1.83 kg and mean gestational age was 34.3 weeks. Tobramycin therapy was initiated within 48 hours of birth and levels were maintained within the therapeutic range. Mean FENa values were persistently elevated during treatment and decreased to the normal range within 2 days of stopping antibiotics. Blood urea and creatinine concentrations were normal throughout the period of study. Exposure to the aminoglycoside appears to delay the previously described postnatal decline in FENa, most likely reflecting subtle renal tubular dysfunction.en
heal.accesscampus-
heal.fullTextAvailabilityTRUE-
heal.identifier.secondaryhttp://www.ncbi.nlm.nih.gov/pubmed/6739186-
heal.journalNamePediatr Pharmacol (New York)en
heal.journalTypepeer-reviewed-
heal.languageen-
heal.publicationDate1984-
heal.recordProviderΠανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικήςel
heal.typejournalArticle-
heal.type.elΆρθρο Περιοδικούel
heal.type.enJournal articleen

Αρχεία

Φάκελος/Πακέτο αδειών

Προβολή: 1 - 1 of 1
Φόρτωση...
Μικρογραφία εικόνας
Ονομα:
license.txt
Μέγεθος:
1.74 KB
Μορφότυπο:
Item-specific license agreed upon to submission
Περιγραφή: